Vice President, Clinical Development (Oncology)

Allogene Therapeutics•South San Francisco, CA

2d•$360,000 - $425,000•Hybrid

About The Position

About Allogene: Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of “off-the-shelf” CAR T cell product candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients. About the role: The Vice President, Clinical Development will work across functions including Clinical Operations, Regulatory Affairs, Translational Science, Safety, Quality and others in supporting our efforts in this exciting new area of cancer immunotherapy. This role is based out of Allogene’s headquarters in South San Francisco, CA. Remote candidates will be evaluated based on suitability for the position along with frequent to travel to Allogene’s South San Francisco or Los Angeles office.

Requirements

MD; completion of residency and oncology fellowship with extensive industry leadership experience in developing oncology treatments experience required; cell therapy experience is highly desirable
Global experience in clinical trial as well as post-marketing setting (cell therapy experience highly preferred but not required)
Strong knowledge and understanding of US, EU and Asian development requirements and general regulatory expectations
Ability to evaluate and manage CROs and other vendors
Excellent organizational skills and an ability to prioritize effectively to deliver results within aggressive timelines with the ability to work independently and as part of a team
Strong interpersonal skills including verbal and written communication are essential in this collaborative work environment
Ability to communicate with internal and external physicians to evaluate specific safety events
Candidates must be authorized to work in the U.S

Nice To Haves

cell therapy experience is highly desirable
Global experience in clinical trial as well as post-marketing setting (cell therapy experience highly preferred but not required)

Responsibilities

Lead the Oncology Clinical Development team, ensuring that the performance of employees is proactively managed and they are coached, trained and developed in order to maximize their contribution
Accountable for the company’s oncology clinical development including clinical trials execution and data collection and analysis
Responsible for development of clinical protocols to support the company’s product strategy, data collection and management and final reports development in compliance with appropriate standard operating procedures, regulatory and medical standards
Collaborate with our head of medical affairs around scientific communication of our clinical data and execution of oncology congress planning and representation and advisory boards
Key member and/or leader of the oncology asset teams in which asset strategy is developed and its execution is overseen
Represent oncology clinical development at senior executive meetings
Identification and communication around opportunities for change and alignment and leadership toward change when necessary
Influence and/or develop broad-based programs and initiatives to meet executive level vision and mission
Collaborate with functional leaders to set strategy and shared objectives and interactions with health agencies and vendors (including CROs)
Represent Allogene at meetings with regulatory authorities and third parties such as licensing or co-development partners, consultants, etc.
Other duties as assigned